Fertility

AMH, FSH, and Antral Follicle Count Compared

Save

Three different tests get lumped together as 'ovarian reserve testing,' and patients are often handed one result without being told what the other two would have added. Comparing what each one actually measures, when it's drawn, and what changes it, makes it easier to read a result for what it is instead of assuming any single number tells the whole story.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What Each Test Actually Measures

AMH, or anti-Müllerian hormone, is a blood test that reflects the pool of small, early-stage follicles in the ovaries; it's gonadotropin-independent and relatively stable across the menstrual cycle, which is part of why it can be drawn on almost any day rather than requiring precise timing 1. Day-3 FSH and estradiol is a different blood draw entirely, timed specifically to the early follicular phase, and it works by measuring how hard the pituitary gland is having to work to recruit follicles — a rising FSH reflects the body compensating for a shrinking pool, not a direct count of anything.

Antral follicle count, or AFC, is neither a blood test nor a hormone measurement — it's a transvaginal ultrasound count of the small follicles visible in both ovaries early in the cycle, read in real time by whoever is performing the scan.

How the Three Tests Compare Side by Side

TestWhat it measuresWhen it's drawnMain limitation
AMHHormone from small folliclesAny day of the cycleAssay can vary somewhat between labs
Day-3 FSH/estradiolPituitary response to declining reserveEarly follicular phase onlyMust be timed correctly or it's uninterpretable
Antral follicle countUltrasound count of visible folliclesEarly follicular phaseDepends on the machine and the person scanning

AMH's main practical advantage is that it doesn't require cycle-day timing, which makes it easier to schedule; AFC's advantage is that it's a direct, current-cycle look at the ovaries rather than an indirect hormonal proxy; and day-3 FSH remains useful largely because it's the longest-established of the three, with the most historical data behind it 1.

Why the Three Results Sometimes Disagree

It's common for AMH, AFC, and FSH to point in slightly different directions for the same person in the same cycle, because they measure related but not identical things through different methods with different sources of error. An AMH result run at one lab using one assay can differ somewhat from the same blood sample run at a different lab, and an AFC count depends partly on the skill and equipment of whoever is scanning that day 1.

When results genuinely conflict, the standard approach isn't to average them or pick a favorite, but to interpret the full pattern alongside age and clinical history rather than anchoring on the single most alarming or most reassuring number in isolation.

What a Result Does and Doesn't Predict

All three tests are used mainly to estimate how the ovaries are likely to respond to ovarian stimulation medication during IVF — roughly how many eggs a retrieval might yield — and a low result on any of them does not, by itself, mean pregnancy isn't possible 1. That distinction gets lost often enough that it's worth stating plainly: these are response-prediction tests, not a yes-or-no verdict on fertility.

Age remains a stronger overall predictor of the chance of pregnancy than any single reserve marker, since fecundity declines gradually starting around the early thirties and more sharply after the late thirties, a pattern that holds regardless of what a specific AMH or AFC number shows 2. A younger patient with a low AMH and an older patient with a normal AMH can face very different odds despite one number looking more reassuring than the other.

Why the Test Matters for What It Changes, Not Just What It Shows

A diagnostic test's real value isn't just how accurately it measures something — it's whether the result changes a decision that actually matters for the patient, since a number that doesn't affect what happens next has limited practical use no matter how precisely it's measured 3. For ovarian reserve testing, that decision is usually the stimulation protocol: a high AMH or AFC signals a strong likely response and raises the risk of ovarian hyperstimulation syndrome, which shifts a clinician toward a lower starting medication dose and specific trigger strategies to reduce that risk 4.

A low result points the opposite direction, often toward a higher starting dose or a different protocol entirely to try to recruit more follicles. In both cases, the number's job is to shape the plan for that specific cycle, not to hand down a verdict on the rest of a patient's fertility.

Egg Quality vs. Egg Quantity: A Different Question Entirely

None of these three tests says anything about egg quality — whether the eggs an ovary produces are chromosomally normal — only about egg quantity, or how many follicles are available to work with. Egg quality vs egg quantity is a genuinely separate question, driven overwhelmingly by age rather than by anything AMH, FSH, or AFC can detect, which is why a young patient with surprisingly low reserve markers can still have good-quality eggs, and an older patient with reassuring reserve numbers can still face a higher chance of chromosomally abnormal embryos.

Conflating the two is one of the most common misreadings of a reserve-test result: a good number describes quantity available this cycle, not a guarantee about the genetic quality of what's retrieved.

High AMH, AFC, and the PCOS Connection

An unusually high AMH or antral follicle count is sometimes the first clue that leads to a PCOS evaluation, since polycystic ovary syndrome is associated with a higher number of small follicles than typical. High AMH and the PCOS connection isn't automatic, though — a high number alone isn't a diagnosis, and PCOS is confirmed using a separate set of clinical and hormonal criteria, not a reserve-test cutoff by itself.

For someone with a high AMH or AFC and no other PCOS features, the more common explanation is simply a strong ovarian reserve for their age, which is worth asking about directly rather than assuming either diagnosis from the number alone.

Which Test to Ask For, and When

Standard fertility-evaluation guidance recommends ovarian reserve testing as one part of a broader workup alongside ovulation assessment and tubal patency testing, rather than as a stand-alone test ordered in isolation 5. In practice, many clinics order AMH and AFC together, since they approach the same question from a blood test and an ultrasound respectively, and reserve day-3 FSH and estradiol for situations where more historical context or a second data point is useful.

A useful starting question for anyone reading fertility testing women blood tests explained material or scheduling a workup is simply which of the three tests the clinic plans to order and why — since not every clinic runs all three by default, and knowing which one is missing is as useful as knowing the results of the ones that were run.

Common questions

None is uniformly "more accurate" than the others — they measure related but different things through different methods, so results sometimes disagree even for the same person in the same cycle. AMH offers timing flexibility, AFC gives a direct current-cycle look via ultrasound, and day-3 FSH has the longest track record. Interpreting the full pattern alongside age matters more than picking one number as the final word.

No. AMH, FSH, and antral follicle count mainly estimate how the ovaries are likely to respond to stimulation medication during IVF, not whether pregnancy is possible at all. A low result on any of them is one data point to factor in alongside age and the rest of a fertility evaluation, not a standalone verdict.

No. All three estimate egg quantity, or how many follicles are available, not egg quality, meaning whether those eggs are chromosomally normal. Egg quality is driven overwhelmingly by age rather than by anything AMH, FSH, or AFC can detect, so a reassuring reserve number doesn't guarantee good-quality eggs, and a low one doesn't rule it out.

Because they assess the ovaries from different angles, and disagreement between them is common enough that a full pattern is more informative than any single result. Many clinics order AMH and AFC together as a blood-and-ultrasound pair and add day-3 FSH and estradiol when more historical context is useful.

No. An unusually high AMH or antral follicle count is sometimes an early clue that prompts a PCOS evaluation, but it isn't a diagnosis on its own. PCOS is confirmed using a separate set of clinical and hormonal criteria, and a high number alone is just as often simply a strong ovarian reserve for that person's age.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Reading a Reserve-Test Result Without Overreading It

  • treating a single low AMH, FSH, or AFC result as a final diagnosis without the rest of a fertility evaluation
  • assuming a reassuring reserve number rules out age-related risk to egg quality
  • skipping a second opinion when reserve-test results and clinical symptoms don't seem to match

This article explains what AMH, FSH, and antral follicle count testing measure and is not a diagnosis. Ovarian reserve results should be interpreted by a reproductive endocrinologist alongside age, symptoms, and the rest of a fertility evaluation.

References

  1. 1.Practice Committee of ASRM (2020). Testing and interpreting measures of ovarian reserve: a committee opinion. American Society for Reproductive Medicine (Fertility and Sterility). linkHow AMH, antral follicle count, and early-follicular FSH/estradiol are each measured and interpreted, and that a low result does not by itself mean a woman cannot conceive.
  2. 2.American College of Obstetricians and Gynecologists (2025). Anticipatory Counseling Regarding Ovarian-Factor Fertility Decline (Committee Statement No. 22). American College of Obstetricians and Gynecologists (Obstetrics & Gynecology). linkThat fecundity declines gradually from the early thirties and more sharply after the late thirties, making age a stronger overall predictor than any single reserve marker.
  3. 3.Schünemann HJ, Oxman AD, Brozek J, et al. (2008). Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. doi:10.1136/bmj.39500.677199.AEThat a diagnostic test's value depends on whether its result changes a management decision, not on accuracy alone — the framing for why reserve testing matters for protocol choice.
  4. 4.Practice Committee of ASRM (2023). Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline. American Society for Reproductive Medicine (Fertility and Sterility). linkThat a strong predicted response (high AMH/AFC) raises OHSS risk and leads clinicians toward lower starting doses and specific trigger strategies to reduce it.
  5. 5.Practice Committee of ASRM (2021). Fertility evaluation of infertile women: a committee opinion. American Society for Reproductive Medicine (Fertility and Sterility). linkThat ovarian reserve testing is recommended as one part of a broader, systematic fertility workup rather than as a stand-alone test.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy